{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:23:37Z","timestamp":1790256217058,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.autrev.2023.103455","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T12:29:25Z","timestamp":1695990565000},"page":"103455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Idiopathic inflammatory myopathies \u2013 The burden of disease: Cohort analysis focusing on damage and comorbidities"],"prefix":"10.1016","volume":"22","author":[{"given":"Ana","family":"Campar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Martins","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Farinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2017.03.005","article-title":"Inflammatory muscle disease: a new landscape","volume":"85","author":"Meyer","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0020","doi-asserted-by":"crossref","first-page":"101484","DOI":"10.1016\/j.berh.2019.101484","article-title":"Inflammatory muscle disease - an update","volume":"34","author":"Baig","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103455_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2023.103455_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103455_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12016-016-8530-2","article-title":"Modern therapies for idiopathic inflammatory myopathies (IIMs): role of biologics","volume":"52","author":"Moghadam-Kia","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2023.103455_bb0045","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10067-009-1181-4","article-title":"Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up","volume":"28","author":"Ng","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1590\/S0482-50042011000500003","article-title":"Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender","volume":"51","author":"Souza","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s42358-018-0030-z","article-title":"Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies","volume":"58","author":"De Souza","year":"2018","journal-title":"Adv Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103455_bb0060","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.autrev.2023.103455_bb0075","series-title":"Quality of life and Pharmacoeconomics in clinical trials, 2nd ed, the health assessment questionnaire 1995 -- status and review","first-page":"227","author":"Ramey","year":"1996"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0080","first-page":"820","article-title":"Why do patients with myositis die? A retrospective analysis of a single-Centre cohort","volume":"34","author":"Amaral Silva","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-019-04910-w","article-title":"Mortality of Chinese patients with polymyositis and dermatomyositis","volume":"39","author":"Yang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103455_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212774","article-title":"Performance of the 2017 European league against rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice","volume":"77","author":"Ho\u010devar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103455_bb0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acr2.11061","article-title":"External validation and evaluation of adding MRI or extended myositis antibody panel to the 2017 EULAR\/ACR myositis classification criteria","volume":"1","author":"Luu","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.autrev.2023.103455_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212701","article-title":"2017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?","volume":"77","author":"Malaviya","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103455_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.40478","article-title":"Consideration of Antisynthetase syndrome features in classifying patients as having idiopathic inflammatory myopathy: comment on the article by Lundberg et al","volume":"70","author":"Casta\u00f1eda","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2023.103455_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2023.103455_bb0115","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/rheumatology\/keaa801","article-title":"Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis Centre","volume":"60","author":"Loarce-Martos","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0120","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/kep355","article-title":"Re-classifying myositis","volume":"49","author":"Sultan","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2023.103455_bb0125","volume":"71","author":"Campar","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0130","first-page":"51","article-title":"An in-depth analysis of our myositis cohort following the example of the EuroMyositis registry","volume":"1","author":"Tomaras","year":"2020","journal-title":"Osteol Rheumatol Open J"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.autrev.2023.103455_bb0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ncl.2014.04.007","article-title":"Idiopathic inflammatory myopathies","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2023.103455_bb0145","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2022-eular.4161","article-title":"Pos0911\u00a0diagnostic value and clinical relevance of muscle biopsy in patients with suspected myositis","volume":"81","author":"Kastrati","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103455_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/21646821.2021.1916730","article-title":"The diagnostic yield of electromyography at detecting abnormalities on muscle biopsy: a single center experience","volume":"61","author":"Moloney","year":"2021","journal-title":"Neurodiagn J"},{"issue":"2","key":"10.1016\/j.autrev.2023.103455_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","article-title":"Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy","volume":"51","author":"Van de Vlekkert","year":"2015","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.autrev.2023.103455_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"5 Suppl 51","key":"10.1016\/j.autrev.2023.103455_bb0170","first-page":"S109","article-title":"Mortality in idiopathic inflammatory myopathies","volume":"26","author":"Lundberg","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103455_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-016-0571-2","article-title":"Mortality in systemic lupus erythematosus: un updated review","volume":"18","author":"Fors Nieves","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.autrev.2023.103455_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10067-019-04744-6","article-title":"Survival analysis of patients with Sj\u00f6gren\u2019s syndrome in Turkey: a tertiary hospital-based study","volume":"39","author":"Yazisiz","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103455_bb0190","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103455_bb0195","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2023.103455_bb0200","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/rheumatology\/kez076","article-title":"Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan","volume":"58","author":"Weng","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"Mars","key":"10.1016\/j.autrev.2023.103455_bb0205","article-title":"Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study","author":"Leclair","year":"2019","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103455_bb0210","first-page":"461","article-title":"Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study","volume":"55","author":"Rai","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"November","key":"10.1016\/j.autrev.2023.103455_bb0215","article-title":"Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies","author":"Xiong","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 9","key":"10.1016\/j.autrev.2023.103455_bb0220","article-title":"Association of dermatomyositis with cardiovascular disease: a case-control study in the all of Us research program [abstract]","volume":"74","author":"Shah","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103455_bb0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jclinepi.2022.03.022","article-title":"The Charlson comorbidity index: problems with use in epidemiological research","volume":"148","author":"Drosdowsky","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s42466-022-00226-4","article-title":"Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019","volume":"4","author":"Pawlitzki","year":"2022","journal-title":"Neurol Res Pract"},{"issue":"11","key":"10.1016\/j.autrev.2023.103455_bb0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11926-019-0862-5","article-title":"Patient-reported outcomes in adult idiopathic inflammatory myopathies","volume":"21","author":"Direnzo","year":"2019","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.autrev.2023.103455_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","article-title":"Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis","volume":"44","author":"Ponyi","year":"2005","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.autrev.2023.103455_bb0250","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103455_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2018.07.013","article-title":"Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis","volume":"18","author":"Barba","year":"2019","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:32:01Z","timestamp":1761600721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1568997223001891"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103455","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic inflammatory myopathies \u2013 The burden of disease: Cohort analysis focusing on damage and comorbidities","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103455"}}